Atlas Trials

A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma

Clinical trial NCT05705583 · UNKNOWN

Trial details

NCT number
NCT05705583
Sponsor
Zhejiang Cancer Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Renal Cell Carcinoma
Start date
2023-01-01
Primary completion
2025-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.